Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection [Phase 1]
Phase 1 bioequivalence study of Doxorubicin Hydrochloride Liposome Injection completed in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.
A pilot study evaluating the Oncogramme assay for predicting induction therapy response in patients with breast cancer and ovarian cancer ha…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse [Phase 3]
A Phase 3 trial comparing Hycamtin (topotecan) plus carboplatin against established regimens for relapsed ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) [Phase 1, Phase 2]
Phase 1/2 INNOVATE trial update examining safety, feasibility, and preliminary activity of combining TTFields therapy at 200 kHz with weekly…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers [Phase 1]
Phase 1 study evaluating MM-121 in combination with paclitaxel in patients with advanced gynecologic cancers and HER2-non-overexpressing bre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 [Phase 2]
Phase 2 Japanese trial (JCOG0206) evaluating chemotherapy followed by cytoreductive surgery for ovarian, fallopian tube, and peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer [Phase 2]
A phase 2 study evaluating the combination of RAD001 (everolimus) and bevacizumab in recurrent ovarian, fallopian tube, and primary peritone…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Tivozanib As Maintenance Therapy In GYN [Phase 2]
Phase 2 trial evaluating tivozanib as maintenance therapy in gynecologic cancers was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating carboplatin plus docetaxel with day 2 pegfilgrastim (Neulasta) in advanced ovarian carcinoma was terminated; result…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission [Phase 2]
A Phase 2 trial evaluating catumaxomab as consolidation therapy for ovarian cancer patients in second or third clinical remission has comple…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer [Phase 2]
Phase 2 trial investigating pazopanib for platinum-resistant advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy [Phase 1]
A Phase 1 trial of a viral therapy in patients with recurrent fallopian tube cancer, recurrent ovarian cancer, or recurrent primary peritone…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
A completed clinical trial investigates preoperative predictors that may determine the likelihood of achieving optimal cytoreductive surgery…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase III trial OVATURE comparing weekly carboplatin with and without phenoxodiol in platinum-resistant recurrent epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study evaluating phenoxodiol in combination with cisplatin or paclitaxel for recurrent ovarian epithelial, fallo…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
The Children's Oncology Group conducted a gene-focused study on tissue samples from younger patients with ovarian or testicular sex cord str…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Phase 3]
Phase 3 trial evaluating octreotide to prevent diarrhea in patients receiving pelvic radiotherapy across multiple pelvic cancers has complet…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Tumor Gene Expression in Women With Ovarian Cancer [Phase 4]
Phase 4 clinical trial update on tumor gene expression in women with ovarian cancer; results were posted on 2016-07-13. The study reports la…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase II trial results for MK-2206, an Akt inhibitor, in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer …
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial evaluating UCN-01 in combination with topotecan in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors [Phase 2]
Phase 2 trial evaluating combination chemotherapy with peripheral stem cell transplantation for germ cell tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer [Phase 1]
This clinical trial update describes a Phase I study of low-dose Whole Abdominal Radiation Therapy (WART) in combination with weekly paclita…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating adding Bevacizumab (Avastin) to carboplatin and paclitaxel in ovarian cancer; results were posted in 2016.